Department of Surgical Sciences, Section of Thoracic Surgery, Uppsala University, Uppsala, Sweden.
Department of Cardiothoracic Surgery and Anesthesia, Uppsala University Hospital, 751 85, Uppsala, Sweden.
J Cardiothorac Surg. 2023 Jan 22;18(1):44. doi: 10.1186/s13019-023-02140-5.
Surgery on the aortic arch and proximal descending thoracic aorta can be lifesaving but is also associated with significant morbidity, ranging from minor infections to severe neurological impairments as well as a substantial risk of mortality. The aim of this study is to clinically assess outcomes, with special regards to neurologic injury, as well as to seek to identify predictors of in-hospital mortality in two patient groups with different underlying aortic pathology, aneurysms and dissections, undergoing arch/descending aortic repair.
34 patients (17 aneurysms, 17 dissections) underwent surgery involving the arch and/or descending aorta, using the Thoraflex or E-Vita frozen elephant trunk graft. 40% were female. Subgroup analysis of aneurysms compared to dissections were performed. Mean follow-up time was 53.9 months and mean age 63.5 years.
In-hospital mortality was 18%. Survival was comparable between aneurysms and dissections. Incidence of spinal cord injury was 9% and stroke 9%. 67% suffered any form of neurological affection, when also cognitive afflictions were included. Perioperative reoperation rate was 29% (bleeding 21%, visceral ischemia 6%, infection 2%), the need for postoperative dialysis was 11% and a series of other minor complications such as atrial fibrillation and pleurocentesis were common.
Postoperative dialysis was found to be a predictor of in-hospital mortality, while both dialysis as well as reoperation due to bleeding and/or visceral ischemia increased the risk for overall mortality, irrespective of preoperative diagnosis. Previous or current smoking appeared to be associated with negative outcomes regarding both in-hospital and overall mortality during follow-up. Trial registration Retrospectively enrolled.
主动脉弓和降主动脉近端的手术可以挽救生命,但也会导致严重的发病率,从轻微的感染到严重的神经损伤,以及相当高的死亡率。本研究的目的是临床评估结果,特别是神经损伤,并试图确定两个不同主动脉病变(动脉瘤和夹层)患者群体在接受主动脉弓/降主动脉修复手术后住院死亡率的预测因素。
34 名患者(17 名动脉瘤,17 名夹层)接受了涉及弓部和/或降主动脉的手术,使用了 Thoraflex 或 E-Vita 冷冻象鼻移植物。40%为女性。对动脉瘤组与夹层组进行了亚组分析。平均随访时间为 53.9 个月,平均年龄为 63.5 岁。
院内死亡率为 18%。动脉瘤和夹层的存活率相当。脊髓损伤的发生率为 9%,中风为 9%。67%的患者出现任何形式的神经损伤,包括认知障碍。围手术期再次手术率为 29%(出血 21%,内脏缺血 6%,感染 2%),需要术后透析的比例为 11%,还有一系列其他较小的并发症,如心房颤动和胸腔穿刺术等较为常见。
术后透析被发现是院内死亡率的预测因素,而透析以及因出血和/或内脏缺血而再次手术都会增加总死亡率的风险,与术前诊断无关。既往或目前吸烟似乎与住院期间和随访期间的总死亡率以及院内死亡率呈负相关。
回顾性注册。